Cargando…
ICAM-1 promotes cancer progression by regulating SRC activity as an adapter protein in colorectal cancer
Colorectal cancer (CRC) has a 5-year survival rate of <10%, as it can metastasize to the lungs and liver. Anticancer drugs and targeted therapies used to treat metastatic colorectal cancer have insufficient therapeutic efficacy and are associated with complications. Therefore, research to develop...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054780/ https://www.ncbi.nlm.nih.gov/pubmed/35487888 http://dx.doi.org/10.1038/s41419-022-04862-1 |